Yayınlar & Eserler

Yayın Ağı
Makaleler 28
Tümü (28)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (17)
ESCI (5)
Scopus (23)
TRDizin (13)

1. The Assessment of Anti-Cancer Effect of Theranekron® on Human Hepatocellular Carcinoma HepG2 Cells

Erzurumlu Y., Dogan H. K., Catakli D.
Proceedings of the National Academy of Sciences India Section B - Biological Sciences , cilt.95, sa.3, ss.527-538, 2025 (Scopus)

2. Nebivolol attenuates acute systemic inflammation induced testicular dysfunction by decreasing transendothelial migration via VCAM-1/MMP-9 signaling

Bas E., Asci H., Erzurumlu Y., BÜYÜKBAYRAM H. İ., Catakli D., Milletsever A., et al.
Journal of Molecular Histology , cilt.56, sa.2, 2025 (SCI-Expanded, Scopus)

3. Cannabidiol Enhances the Anticancer Activity of Etoposide on Prostate Cancer Cells

ERZURUMLU Y., ÇATAKLI D.
Cannabis and Cannabinoid Research , cilt.10, sa.2, ss.258-276, 2025 (SCI-Expanded, Scopus)

4. Kannabidiolün Lipopolisakkarit ile İndüklenen Gebelik Enflamasyon Modelindeki Sıçan Maternal ve Fetal Beyin Dokuları Üzerindeki Koruyucu Etkilerinin İncelenmesi

Catakli D., Erzurumlu Y., Ertunc O., Sezer S.
Namık Kemal Tıp Dergisi , cilt.13, sa.1, ss.13-23, 2025 (ESCI, TRDizin)

5. Evaluation of cytoprotective effects of cannabidiol on neuroinflammation and neurogenesis process in rat offsprings

ÇATAKLI D., ERZURUMLU Y., AŞCI H., SAVRAN M., SEZER S.
Reproductive Toxicology , cilt.132, 2025 (SCI-Expanded, Scopus)

6. Evaluation of single and multiple hyaluronic acid injections at different concentrations with high molecular weight in the treatment of knee osteoarthritis

Safali S., Ertaş E. S., Özdemir A., ÇATAKLI D.
BMC Musculoskeletal Disorders , cilt.25, sa.1, 2024 (SCI-Expanded, Scopus) Creative Commons License

7. HEK293 İNSAN EMBRİYONİK BÖBREK HÜCRELERİNDE KATLANMAMIŞ PROTEİN YANITI SİNYALİ BİLEŞENLERİNİN SİRKADİYEN SALINIM MODELİNİN BELİRLENMESİ

ERZURUMLU Y., DOGAN H. K., CATAKLI D.
Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.48, sa.3, ss.949-961, 2024 (Scopus, TRDizin) Creative Commons License

8. Curcumin synergistically augments the chemotherapeutic activity of doxorubicin in prostate cancer cells

ERZURUMLU Y., ÇATAKLI D., DOĞAN H. K.
Interdisciplinary medical journal , cilt.15, sa.51, ss.10-19, 2024 (TRDizin) Creative Commons License

9. Potential Hepatoprotective Effects of Irbesartan, an Accessible Angiotensin II Receptor Blocker, Against Cisplatin-Induced Liver Injury in a Rat Model

ERTUNÇ O., ERZURUMLU Y., SAVRAN M., ÇATAKLI D., Doğan Kiran E., PEKGÖZ Ş.
Turkish Journal of Pharmaceutical Sciences , cilt.21, sa.2, ss.88-94, 2024 (ESCI, Scopus, TRDizin)

10. New mode of action of curcumin on prostate cancer cells: Modulation of endoplasmic reticulum‐associated degradation mechanism and estrogenic signaling

Erzurumlu Y., Dogan H. K., Çataklı D.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , cilt.38, sa.2, ss.1-12, 2024 (SCI-Expanded, Scopus)

11. Anticancer Effect of Theranekron® on Androgen-Dependent Prostate Cancer Cells

ERZURUMLU Y., Doğan H. K., ÇATAKLI D.
Turkish Journal of Pharmaceutical Sciences , cilt.20, sa.6, ss.368-373, 2023 (ESCI, Scopus, TRDizin)

12. Estrogens drive the endoplasmic reticulum-associated degradation and promote proto-oncogene c-Myc expression in prostate cancer cells by androgen receptor/estrogen receptor signaling

ERZURUMLU Y., Dogan H. K., ÇATAKLI D., Aydogdu E., MUHAMMED M. T.
Journal of Cell Communication and Signaling , cilt.17, sa.3, ss.793-811, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Caffeine Expands the Cisplatin-Induced Cell Death by Strengthening eIF2α/ATF4/CHOP Signaling and Blocking Autophagic Flux in Human Prostate Cancer Cells

ERZURUMLU Y., Dogan H. K., ÇATAKLI D.
Applied In Vitro Toxicology , cilt.9, sa.3, ss.78-89, 2023 (Scopus)

14. Asetilsalisilik Asit ve Salisilik Asitin Paklitaksel ile Eş Uygulamasının Prostat Kanseri Hücreleri Üzerindeki Olası Sinerjistik Etkilerinin Otofaji, ER stresi ve Apoptotik Hücre Ölümü ile İlişkisinin Araştırılması

Erzurumlu Y., Catakli D., Doğan H. K.
Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi , cilt.14, sa.2, ss.87-99, 2023 (TRDizin) Creative Commons License

15. HERPUD1, a Member of the Endoplasmic Reticulum Protein Quality Control Mechanism, may be a Good Target for Suppressing Tumorigenesis in Breast Cancer Cells

ERZURUMLU Y., Doğanlar Y., Doğan H. K., ÇATAKLI D.
Turkish Journal of Pharmaceutical Sciences , cilt.20, sa.3, ss.157-164, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

16. Dexamethasone-stimulated glucocorticoid receptor signaling positively regulates the endoplasmic reticulum-associated degradation (ERAD) mechanism in hepatocellular carcinoma cells

ERZURUMLU Y., Dogan H. K., ÇATAKLI D.
Steroids , cilt.195, 2023 (SCI-Expanded, Scopus)

17. Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells

ERZURUMLU Y., ÇATAKLI D., Dogan H. K.
Journal of Natural Medicines , cilt.77, sa.3, ss.572-583, 2023 (SCI-Expanded, Scopus)

18. Cannabidiol Negatively Regulates Androgenic Signal in Prostate Cancer Cells and Fine-Tunes the Tumorigenesis by Modulating Endoplasmic Reticulum-Associated Degradation, Unfolded Protein Response, and Autophagy

ERZURUMLU Y., ÇATAKLI D., SEZER S.
Revista Brasileira de Farmacognosia , cilt.33, sa.2, ss.316-325, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Caffeine May Improve the Chemotherapeutic Effect of Docetaxel by Inducing Unfolded Protein Response and Autophagy in Breast Cancer Cells

ERZURUMLU Y., ÇATAKLI D., Doğan H. K., AYDOĞDU E.
FABAD Journal of Pharmaceutical Sciences , cilt.48, sa.1, ss.91-104, 2023 (Scopus, TRDizin)

20. 1,25(OH)2 D3 induced vitamin D receptor signaling negatively regulates endoplasmic reticulum-associated degradation (ERAD) and androgen receptor signaling in human prostate cancer cells

ERZURUMLU Y., Aydogdu E., Dogan H. K., ÇATAKLI D., MUHAMMED M. T., Buyuksandic B.
Cellular Signalling , cilt.103, 2023 (SCI-Expanded, Scopus)

21. Progesterone regulates the endoplasmic reticulum-associated degradation and Unfolded Protein Response axis by mimicking the androgenic stimulation in prostate cancer cells

ERZURUMLU Y., Dogan H. K., ÇATAKLI D.
Molecular Biology Reports , cilt.50, sa.2, ss.1253-1265, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Circadian Oscillation Pattern of Endoplasmic Reticulum Quality Control (ERQC) Components in Human Embryonic Kidney HEK293 Cells

ERZURUMLU Y., ÇATAKLI D., Dogan H. K.
Journal of Circadian Rhythms , cilt.21, sa.1, ss.1-15, 2023 (Scopus) Creative Commons License

23. CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS ZERDEÇALIN BİYOAKTİF BİLEŞİĞİ KURKUMİN, GEMSİTABİNİN PROSTAT KANSERİ HÜCRELERİNDEKİ ANTİ-MALİGNANT ÖZELLİĞİNİ GELİŞTİREBİLİR

ERZURUMLU Y., Dogan H. K., ÇATAKLI D.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.47, sa.3, 2023 (Scopus, TRDizin) Creative Commons License

24. Thymol Reduces the Lipopolysaccharide-Induced Acute Kidney Inflammation by Modulating Lysosomal Stress

ERZURUMLU Y., Dogan H. K., ÇATAKLI D.
Journal of Research in Pharmacy , cilt.27, sa.1, ss.375-385, 2023 (Scopus, TRDizin)

25. Ramelteon Protects Intestinal Tissue Against Injury Caused by Methotrexate Via Showing Anti-apoptotic, Antiinflammatory and Antioxidant Properties

Çataklı D., Sevük M. A., Coşan S., İmeci O. B., Keskin E., Sevinç Y. S., et al.
BEZMIALEM SCIENCE , cilt.10, sa.6, ss.770-776, 2022 (ESCI, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

26. INHIBITION OF IRE1α/XBP-1 BRANCH OF UPR BY GSK2850163 DRIVES THE SENSITIVITY TO TAMOXIFEN IN BREAST CANCER CELLS

ERZURUMLU Y., Doğan H. K., ÇATAKLI D.
Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.46, sa.3, ss.839-852, 2022 (Scopus) Creative Commons License

27. Tarantula cubensis Extract Induces Cell Death in Prostate Cancer by Promoting Autophagic Flux/ER Stress Responses and Decreased Epithelial-Mesenchymal Transition

ERZURUMLU Y., Dogan H. K., ÇATAKLI D., Aydogdu E.
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY , cilt.32, sa.4, ss.575-582, 2022 (SCI-Expanded, Scopus)

28. A23187 Tamoksifene Dirençli Meme Kanseri Hücrelerinin Tamoksifen Duyarlılığını Geliştirebilir

ERZURUMLU Y., ÇATAKLI D.
Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi , cilt.9, sa.2, ss.222-227, 2022 (Hakemli Dergi) Creative Commons License
Kitaplar 1

1. Kalp Yetersizliği ve Tedavisinde Yeni Hedefler

Çataklı D.
Türkiye Klinikleri Eczacılık Bilimleri , Zeliha Kerry,Tahir Yağdı, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.40-43, 2023 Creative Commons License
Metrikler

Yayın

29

Yayın (WoS)

17

Yayın (Scopus)

23

Atıf (Scopus)

93

H-İndeks (Scopus)

6

Atıf (Scholar)

6

H-İndeks (Scholar)

1

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

1

Proje

3

Açık Erişim

10
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER